FFCP PHASE1:Hg19::chr16:81031088..81031097,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p12@C16orf61 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_12_at_C16orf61_5end |
| Coexpression cluster: | C5_Hepatocyte_liver_hepatocellular_Intestinal_kidney_small_pancreas |
| Association with transcript: | -89bp_to_DQ890780, DQ893939_5end |
| EntrezGene: | C16orf61 |
| HGNC: | 24447 |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p12@C16orf61 |
|---|
0.0
1.0
2.0
3.0
4.0
5.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
